BGM (BGM) | Stock Overview & Key Data
BGM Performance Comparison
Stock Range
Today's Range
Low: $9.32
High: $9.90
on October 6, 2025
52 Week Range
Low: $6.22
High: $17.17
on November 14, 2024
on June 11, 2025
All-Time High: $110.00 on January 11, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.9B
EPS
-0.29
P/E Ratio (TTM)
15.00
Forward P/E
N/A
P/B Ratio
5.16
PEG Ratio
N/A
Div. Yield
N/A
ROE
-16.52%
Beta
1.457
Debt to Equity
0.22
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-5.41%
Profit Margin
-26.32%
Returns and Earnings
Return on Assets (TTM)
-3.84%
Return on Equity (TTM)
-16.52%
EBITDA
$1.8M
Net Income (TTM)
$-7.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.13
Quarterly Revenue Growth (YoY)
-56.90%
Quarterly Earnings Growth (YoY)
-16.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| BGM BGM | 1.91B Small-cap | 3.02% | 35.06% | -1.00% | -6.78% | 10.74% | 37.88% | 58.40% | -77.37% |
| Zoetis ZTS | 65.09B Large-cap | 2.03% | -3.94% | -8.02% | -8.26% | -9.96% | -22.95% | -0.64% | -11.49% |
| Haleon Plc - ADR HLN | 41.44B Large-cap | -0.57% | -9.75% | -13.40% | -5.18% | -6.89% | -12.54% | 45.53% | 18.62% |
| Tilray Brands TLRY | 1.81B Small-cap | -14.59% | 41.07% | 216.00% | 172.41% | 8.22% | -3.07% | -49.68% | -71.58% |
| Harrow HROW | 1.68B Small-cap | -12.89% | 6.01% | 34.44% | 82.59% | 15.32% | -16.86% | 249.88% | 621.92% |
| BioCryst BCRX | 1.55B Small-cap | -7.02% | -14.29% | -19.86% | 3.39% | -10.34% | -5.52% | -48.12% | 82.34% |
Ownership & Short Interest
Insider Ownership
7.29%
Institutional Ownership
0.00%
Shares Short
7K
Short Ratio
0.17
Short % of Shares Outstanding
0.43%
Average 10-Day Volume
36K
Average 90-Day Volume
50K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BGM's 52-week high and low?
- In the last 52 weeks, BGM reached a high of $17.17 (on June 11, 2025) and a low of $6.22 (on November 14, 2024).
- What is the market cap and P/E ratio for BGM?
- Curious about BGM's size and valuation? Its market capitalization stands at 1.91B. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.00, and the forward P/E (looking ahead) is N/A.
- Does BGM pay dividends? If so, what's the yield?
- As for dividends, BGM isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are BGM's main competitors or similar companies to consider before investing?
When looking at BGM, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.09B Healthcare Drug Manufacturers - Specialty & Generic -22.95% -0.64% Haleon Plc - ADR
HLN41.44B Healthcare Drug Manufacturers - Specialty & Generic -12.54% 45.53% Tilray Brands
TLRY1.81B Healthcare Drug Manufacturers - Specialty & Generic -3.07% -49.68% Harrow
HROW1.68B Healthcare Drug Manufacturers - Specialty & Generic -16.86% 249.88% BioCryst
BCRX1.55B Healthcare Drug Manufacturers - Specialty & Generic -5.52% -48.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for BGM Group Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of BGM's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -16.52%, the Debt to Equity ratio from the most recent quarter is 0.22, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BGM?
- Looking at BGM's growth, its revenue over the trailing twelve months (TTM) was $30M. Compared to the same quarter last year (YoY), quarterly revenue grew by -56.90%, and quarterly earnings saw a YoY growth of -16.40%.
- How much of BGM stock is held by insiders and institutions?
- Wondering who owns BGM stock? Company insiders (like executives and directors) hold about 7.29% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.